Abstract
The first review regarding the potential of aurones as promising drug candidates was reported in 2003. Since, considerable efforts have been made to explore the pharmacological and therapeutical activities of aurones. In this regard, many biological areas were concerned, including major pathological, such as cancer and neurodegenerative disorders. The aim of the present report is to highlight the progress made during the last ten years on the medicinal chemistry of aurones. A special focus will be made on the structure-activity relationship aspects among aurones and especially in case where aurones were found highly active than the corresponding flavones and chalcones.
Keywords: Alzheimer’s disease, antioxidants, aureusidin, antiviral, aurones, cancer, cytotoxicity, flavonoids, hepatitis C, kinases, sulfuretin, tyrosinase
Current Medicinal Chemistry
Title:Recent Advances in the Medicinal Chemistry of Aurones
Volume: 19 Issue: 18
Author(s): R. Haudecoeur and A. Boumendjel
Affiliation:
Keywords: Alzheimer’s disease, antioxidants, aureusidin, antiviral, aurones, cancer, cytotoxicity, flavonoids, hepatitis C, kinases, sulfuretin, tyrosinase
Abstract: The first review regarding the potential of aurones as promising drug candidates was reported in 2003. Since, considerable efforts have been made to explore the pharmacological and therapeutical activities of aurones. In this regard, many biological areas were concerned, including major pathological, such as cancer and neurodegenerative disorders. The aim of the present report is to highlight the progress made during the last ten years on the medicinal chemistry of aurones. A special focus will be made on the structure-activity relationship aspects among aurones and especially in case where aurones were found highly active than the corresponding flavones and chalcones.
Export Options
About this article
Cite this article as:
Haudecoeur R. and Boumendjel A., Recent Advances in the Medicinal Chemistry of Aurones, Current Medicinal Chemistry 2012; 19 (18) . https://dx.doi.org/10.2174/092986712800672085
DOI https://dx.doi.org/10.2174/092986712800672085 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modelling and Treating Amyotrophic Lateral Sclerosis through Induced- Pluripotent Stem Cells Technology
Current Stem Cell Research & Therapy From the Editors Perspective: Rational Approaches for Radical Entities
Current Neurovascular Research Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews Alcoholism and its Effects on the Central Nervous System
Current Neurovascular Research Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
Current Gene Therapy Huntingtons Disease: The Value of Transcranial Meganetic Stimulation
Current Medicinal Chemistry Meet Our Associate Editor
Current Molecular Medicine Oxytosis: A Novel Form of Programmed Cell Death
Current Topics in Medicinal Chemistry Neuropathological Correlates of Cerebral Multimorbidity
Current Alzheimer Research Electroporation Gene Therapy: New Developments In Vivo and In Vitro
Current Gene Therapy MtDNA As a Cancer Marker: A Finally Closed Chapter?
Current Genomics Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases
Current Protein & Peptide Science Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
CNS & Neurological Disorders - Drug Targets Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Current Alzheimer Research Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain
Current Medicinal Chemistry Modulation of Cell Death in Age-Related Diseases
Current Pharmaceutical Design <i>In silico</i> Screening of Pyridoxine Carbamates for Anti-Alzheimer’s Activities
Central Nervous System Agents in Medicinal Chemistry Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
Current Neuropharmacology β -Amyloid: A Disease Target or a Synaptic Regulator Affecting Age-Related Neurotransmitter Changes?
Current Pharmaceutical Design Editorial [Hot Topic: Nitric Oxide: Implications for the Etiology & Treatment of Central Nervous System Disorders (Guest Editor: Giuseppe Di Giovanni)]
CNS & Neurological Disorders - Drug Targets